eBay Inc vs IDEXX Laboratories, Inc. — how do they compare? eBay Inc trades at $113.09 (market cap $49.83B), while IDEXX Laboratories, Inc. trades at $519.93 (market cap $40.43B). The key difference: eBay Inc is the larger of the two by market cap, and eBay Inc pays a 1.11% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| EBAY | IDXX | |
|---|---|---|
Market Cap | $49.83B | $40.43B |
Volume | 2,986,953 | 692,164 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $766.68 |
52-Week Low | $79.41 | $504.70 |
Typical Hold Time | 134 Days | 46 Days |
Enterprise Value | $53.65B | $41.32B |
Dividend Yield | 1.11% | — |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $112.41, up 4.47% today, showing strong momentum with three consecutive quarterly earnings beats. The stock exhibits bullish technical signals with moving averages supporting upward trends, while fundamentals reveal robust profitability with 72.05% gross margins and 47.38% ROE. Recent news highlights strategic focus on collectibles and live commerce growth, though competition intensifies as Amazon introduces multi-platform seller tools.
Outlook remains positive with analyst consensus at $117.68 target (4.7% upside), though risks include potential acquisition uncertainty from GameStop's stake and slowing advertising growth. The company's strong cash flow generation and consistent earnings performance support continued investor confidence, but monitoring competitive pressures and execution of growth initiatives is crucial for sustained outperformance.
IDEXX Laboratories (IDXX) trades at $517.47, up 2.13% with strong earnings momentum after beating Q2 2026 estimates. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and expanded diagnostic platforms highlight growth initiatives, while analyst consensus remains bullish with a $665 price target representing 28.5% upside potential.
The outlook remains positive given consistent earnings beats and expanding veterinary diagnostics market share. Key risks include FX headwinds, weaker U.S. vet visits, and premium valuations at 36x P/E. Institutional ownership trends show mixed activity with recent insider selling, but long-term growth drivers in pet healthcare innovation support the bullish analyst stance.
Trailing returns across standard periods
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →